FALCON POINT CAPITAL, LLC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 52 filers reported holding NEOS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FALCON POINT CAPITAL, LLC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$350,000
-83.7%
72,201
-78.9%
0.08%
-82.1%
Q2 2018$2,141,000
-34.4%
342,621
-12.9%
0.42%
-35.7%
Q1 2018$3,266,000
+396.4%
393,512
+509.8%
0.65%
+488.3%
Q4 2017$658,000
-45.4%
64,530
-44.3%
0.11%
-36.6%
Q3 2017$1,205,000
+35.9%
115,869
-4.7%
0.18%
+45.8%
Q2 2017$887,000
+39.5%
121,563
+37.7%
0.12%
+41.2%
Q1 2017$636,000
+26.9%
88,279
+3.1%
0.08%
+26.9%
Q4 2016$501,000
+22.8%
85,588
+23.8%
0.07%
+8.1%
Q3 2016$408,00069,1350.06%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,043,770$7,620,0002.51%
Stonepine Capital Management, LLC 565,100$4,125,0002.23%
DAFNA Capital Management LLC 209,873$1,532,0001.09%
Ghost Tree Capital, LLC 500,000$3,650,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,459,195$10,652,0000.57%
PURA VIDA INVESTMENTS, LLC 150,000$1,095,0000.44%
J. Goldman & Co LP 845,000$6,169,0000.33%
ESSEX INVESTMENT MANAGEMENT CO LLC 191,729$1,400,0000.20%
Opaleye Management Inc. 50,000$365,0000.15%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 50,000$365,0000.15%
View complete list of NEOS THERAPEUTICS INC shareholders